US CPI report release is already behind us and markets' attention once again shifts towards central banks with release of the FOMC minutes and an expected 50 bp rate hike from RBNZ. Apart from that, investors' attention will also be drawn to retail sales data from the US as well as inflation figures from Canada. Be sure to watch GOLD, AUDNZD and USDCAD next week!
GOLD
Start investing today or test a free demo
Open real account TRY DEMO Download mobile app Download mobile appGold tested the $1,800 resistance area last week, underpinned by a sharp retreat in the dollar following the release of lower-than-expected US inflation numbers for July. Nevertheless FED members indicated their commitment to keep raising interest rates until they see compelling evidence that inflation sustainably declines. Therefore, FOMC minutes released on Wednesday, 7:00 pm BST is a key macro report for gold traders next week, as it may provide more insights regarding the central bank's stance on monetary policy.
AUDNZD
The Reserve Bank of New Zealand is set to review its monetary policy settings on Wednesday. Markets expect a 50 bps rate hike, however investors will mostly focus on comments regarding the future path of rates for the RBNZ. House prices in New Zealand fell in July as high inflation and rising interest rates weighed on demand. Recent data also showed that near-term inflation expectations in the country are forecasted to slow in the third quarter of 2022. Therefore some analysts expect that the pace of interest rates hikes may slow down in the upcoming months. On Tuesday investors will be served RBA Minutes which may also boost volatility on AUDNZD.
USDCAD
FOMC minutes on Wednesday is not the only release which may have impact on the US dollar. USDCAD currency pair is likely to remain active next week as two important macro reports are set to be released - US retail sales report for July (Wednesday, 1:30 pm BST) and Canadian CPI report for July (Tuesday, 1:30 pm BST). Data should provide more information regarding price pressures in both economies.
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.